Litcius/Paper detail

Randomized Phase 3, Double-Blind, Placebo-Controlled Study of Prophylactic Gabapentin for the Reduction of Oral Mucositis Pain During the Treatment of Oropharyngeal Squamous Cell Carcinoma

Andrew Cook, Ankit Modh, Haythem Ali, Jawad Sheqwara, Steven Chang, Tamer Ghanem, Suhael Momin, Vivian Wu, Samantha Tam, Sarah Money, Xiaoxia Han, Lamis Fakhoury, Benjamin Movsas, Farzan Siddiqui

2021International Journal of Radiation Oncology*Biology*Physics20 citationsDOI

Topics & Concepts

MedicineMucositisGabapentinCommon Terminology Criteria for Adverse EventsPlaceboAdverse effectQuality of life (healthcare)Clinical endpointHead and neck cancerBrief Pain InventoryRandomized controlled trialInternal medicineRadiation therapyPhysical therapyChronic painNursingAlternative medicinePathologyOral health in cancer treatmentHead and Neck Cancer StudiesPain Management and Opioid Use
Randomized Phase 3, Double-Blind, Placebo-Controlled Study of Prophylactic Gabapentin for the Reduction of Oral Mucositis Pain During the Treatment of Oropharyngeal Squamous Cell Carcinoma | Litcius